Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy of hyperlipidemia]

C Keller1

  • 1Medizinischen Poliklinik, Klinikums Innenstadt der Ludwig-Maximilians-Universität München, Deutschland.

Wiener Medizinische Wochenschrift (1946)
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limits to timescale dependence in erosion rates: Quantifying glacial and fluvial erosion across timescales.

Science advances·2024
Same author

Hepcidin-The Culprit Explaining Disturbed Iron Homeostasis in Chronic Renal Disease?: IL-6 Mediates Hypoferremia of Inflammation by Inducing the Synthesis of the Iron Regulatory Hormone Hepcidin. J Clin Invest 113:1271-1276, 2004.

Journal of the American Society of Nephrology : JASN·2023
Same author

Distribution of Copper and Cadmium Fractions in Two Forest Soils.

Journal of environmental quality·2021
Same author

[Perioperative infusion therapy in children : Are infusion sets with precision flow regulators suitable for pediatric anesthesia?]

Der Anaesthesist·2019
Same author

Lead, zinc, and copper redistributions in soils along a deposition gradient from emissions of a Pb-Ag smelter decommissioned 100 years ago.

The Science of the total environment·2019
Same author

Evaluation of historical atmospheric pollution in an industrial area by dendrochemical approaches.

Chemosphere·2018
Same journal

A One Health digital twin framework for leprosy: linking host, pathogen, and population dynamics.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

[Changed profile of requirements in pediatric prehospital emergency care-a retrospective analysis of the Karlsruhe pediatric ambulance service].

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Post-pandemic rebound of rotavirus and adenovirus in pediatric gastroenteritis: a 6-year antigen-based surveillance study from Turkey.

Wiener medizinische Wochenschrift (1946)·2026
See all related articles

Identifying patients with monogenetic lipid disorders is crucial for intensive cholesterol-lowering therapy. This approach aims to normalize cholesterol levels and prevent early coronary death using potent new drugs.

Area of Science:

  • Cardiology
  • Genetics
  • Metabolic Disorders

Context:

  • Monogenetic lipid disorders significantly increase the risk of premature coronary heart disease.
  • Early identification is essential for effective intervention.
  • Intensive cholesterol-lowering therapy is a key management strategy.

Purpose:

  • To highlight the necessity of identifying patients with monogenetic lipid disorders.
  • To emphasize the goal of intensive cholesterol-lowering therapy in preventing premature coronary heart disease.
  • To underscore the potential of novel potent drugs in managing these conditions.

Summary:

  • Accurate identification of patients with monogenetic lipid disorders is a prerequisite for initiating intensive cholesterol-lowering therapy.
  • The primary objective is to normalize serum cholesterol levels.

Related Experiment Videos

  • This therapeutic strategy aims to prevent early coronary death.

    • Impact:

    • Enables targeted treatment for high-risk individuals.
    • Facilitates the prevention of premature cardiovascular events.
    • Demonstrates the potential of advanced pharmacological interventions in managing severe lipid disorders.